As JN.1 emerges as variant of interest, time to evaluate preparedness and effective testing and treatments
WHO classifies JN.1 as a separate variant of interest (VOI) with potential to affect virus characteristics & increase burden of respiratory infections. Vaccines expected to increase protection against JN.1. India detects 21 cases, all mild.
The Hindu ·